Trial Outcomes & Findings for Pharmacist Provision of Medication Abortion (NCT NCT04956731)
NCT ID: NCT04956731
Last Updated: 2024-09-23
Results Overview
Negative Pregnancy Test
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
10 participants
Primary outcome timeframe
6 weeks
Results posted on
2024-09-23
Participant Flow
Participant milestones
| Measure |
Pharmacist Provision of Medication Abortion
This is a single arm study with 10 participants undergoing start to finish medication abortion provided by a pharmacist.
Pharmacist Provision of Medication Abortion: Pharmacists providing start to finish medication abortions
|
|---|---|
|
Overall Study
STARTED
|
10
|
|
Overall Study
COMPLETED
|
10
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Pharmacist Provision of Medication Abortion
Baseline characteristics by cohort
| Measure |
Pharmacist Provision of Medication Abortion
n=10 Participants
This is a single arm study with 10 participants undergoing start to finish medication abortion provided by a pharmacist.
Pharmacist Provision of Medication Abortion: Pharmacists providing start to finish medication abortions
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
10 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
10 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
10 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 6 weeksNegative Pregnancy Test
Outcome measures
| Measure |
Pharmacist Provision of Medication Abortion
n=10 Participants
This is a single arm study with 10 participants undergoing start to finish medication abortion provided by a pharmacist.
Pharmacist Provision of Medication Abortion: Pharmacists providing start to finish medication abortions
|
|---|---|
|
Completion of Medication Abortion
|
9 Participants
|
SECONDARY outcome
Timeframe: 2 weeks following completion of medication abortionPopulation: only 9 of the 10 participants completed post-abortion interview
qualitative analysis of post abortion in depth interviews
Outcome measures
| Measure |
Pharmacist Provision of Medication Abortion
n=9 Participants
This is a single arm study with 10 participants undergoing start to finish medication abortion provided by a pharmacist.
Pharmacist Provision of Medication Abortion: Pharmacists providing start to finish medication abortions
|
|---|---|
|
Patient Satisfaction, # of Patients Reporting "Very Satisfied"
|
9 Participants
|
SECONDARY outcome
Timeframe: 2 weeks following completion of all 10 medication abortion visitsqualitative analysis of post pilot in depth interviews
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 2 weeks following completion of all 10 medication abortion visitsper recommendation by participating pharmacists at post pilot in depth interviews
Outcome measures
Outcome data not reported
Adverse Events
Pharmacist Provision of Medication Abortion
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Office of Clinical Trials Administration
University of California, San Diego
Phone: 858-822-2940
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place